- Home
- MYFW vs CRVS Comparison
MYFW vs CRVS Comparison
Compare MYFW & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- CRVS
- Stock Information
- Founded
- MYFW 2002
- CRVS 2014
- Country
- MYFW United States
- CRVS United States
- Employees
- MYFW N/A
- CRVS N/A
- Industry
- MYFW Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- CRVS Health Care
- Exchange
- MYFW Nasdaq
- CRVS Nasdaq
- Market Cap
- MYFW 201.1M
- CRVS 459.0M
- IPO Year
- MYFW 2018
- CRVS 2016
- Fundamental
- Price
- MYFW $22.74
- CRVS $5.79
- Analyst Decision
- MYFW Buy
- CRVS Strong Buy
- Analyst Count
- MYFW 2
- CRVS 4
- Target Price
- MYFW $24.25
- CRVS $15.00
- AVG Volume (30 Days)
- MYFW 26.2K
- CRVS 547.2K
- Earning Date
- MYFW 10-23-2025
- CRVS 11-11-2025
- Dividend Yield
- MYFW N/A
- CRVS N/A
- EPS Growth
- MYFW 226.95
- CRVS N/A
- EPS
- MYFW 1.18
- CRVS N/A
- Revenue
- MYFW $93,514,000.00
- CRVS N/A
- Revenue This Year
- MYFW $14.41
- CRVS N/A
- Revenue Next Year
- MYFW $12.25
- CRVS N/A
- P/E Ratio
- MYFW $19.58
- CRVS N/A
- Revenue Growth
- MYFW 16.68
- CRVS N/A
- 52 Week Low
- MYFW $17.10
- CRVS $2.54
- 52 Week High
- MYFW $24.88
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- MYFW 49.52
- CRVS 56.88
- Support Level
- MYFW $22.33
- CRVS $5.64
- Resistance Level
- MYFW $23.74
- CRVS $6.09
- Average True Range (ATR)
- MYFW 0.66
- CRVS 0.34
- MACD
- MYFW -0.03
- CRVS -0.05
- Stochastic Oscillator
- MYFW 58.13
- CRVS 50.00
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).